Over the past 12 months, 3 insiders at Viridian Therapeutics, Inc.\DE filed 3 open-market SEC Form 4 transactions on VRDN: 2 purchases worth $30.0M and 1 sale worth $71K. Insiders have been net buyers over this period. The most recent filing was on May 11, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 26 | Fairmount Funds Management Llc | BUY | 1.18M | $17.00 | $20.0M |
| Dec 31, 25 | Jennifer TousignantChief Legal Officer | SELL | 2.3K | $31.16 | $71K |
| Oct 23, 25 | Fairmount Healthcare Fund II Gp LlcDirector,TenPercentOwner | BUY | 454.5K | $22.00 | $10.0M |
| Sep 27, 24 | Thomas W. BeethamChief Operating Officer | BUY | 5.0K | $23.41 | $117K |
| Sep 27, 24 | Stephen F. MahoneyPresident and CEO | BUY | 21.4K | $23.33 | $499K |
| Sep 13, 24 | Fairmount Healthcare Fund II L.p.Director,TenPercentOwner | BUY | 1.60M | $18.75 | $30.0M |
| Jan 22, 24 | Fairmount Healthcare Fund II L.p.Director,TenPercentOwner,Other | BUY | 476.2K | $21.00 | $10.0M |
| Jun 16, 23 | Lara MeisnerChief Legal Officer | SELL | 27 | $28.35 | $765 |
| Jun 15, 23 | Lara MeisnerChief Legal Officer | SELL | 2.3K | $28.02 | $64K |
| Jun 6, 23 | Lara MeisnerChief Legal Officer | SELL | 5.1K | $25.02 | $128K |
| Jun 5, 23 | Lara MeisnerChief Legal Officer | SELL | 499 | $25.03 | $12K |
| Jun 2, 23 | Lara MeisnerChief Legal Officer | SELL | 1.9K | $24.21 | $45K |
| Apr 12, 23 | Scott Dunseth MyersChief Executive Officer | BUY | 4.0K | $25.37 | $101K |
| Mar 13, 23 | Scott Dunseth MyersChief Executive Officer | BUY | 5.5K | $29.15 | $160K |
| Mar 9, 23 | Lara MeisnerGeneral Counsel and Secretary | SELL | 30.0K | $29.07 | $871K |
| Feb 2, 23 | Jonathan ViolinChief Executive Officer | SELL | 50.0K | $36.80 | $1.8M |
| Jan 23, 23 | Lara MeisnerGeneral Counsel and Secretary | SELL | 6.8K | $35.66 | $244K |
| Jan 17, 23 | Barrett KatzChief Medical Officer | SELL | 24.9K | $37.21 | $925K |
| Jan 13, 23 | Barrett KatzChief Medical Officer | SELL | 4.1K | $37.01 | $153K |
| Jan 10, 23 | Barrett KatzChief Medical Officer | SELL | 47.4K | $35.30 | $1.7M |
| Jan 9, 23 | Barrett KatzChief Medical Officer | SELL | 12.6K | $33.04 | $417K |
| Dec 21, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 16.3K | $29.19 | $477K |
| Dec 20, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 600 | $28.07 | $17K |
| Dec 16, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 1.3K | $28.44 | $37K |
| Dec 15, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 300 | $28.08 | $8K |
| Dec 14, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 15.7K | $28.12 | $440K |
| Dec 12, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 600 | $28.05 | $17K |
| Nov 15, 22 | Lara MeisnerGeneral Counsel and Secretary | SELL | 8.1K | $22.05 | $179K |
| Aug 17, 22 | Fairmount Healthcare Fund Gp LlcDirector,TenPercentOwner | BUY | 425.5K | $23.50 | $10.0M |
| Jun 1, 22 | Jonathan ViolinChief Executive Officer | SELL | 30.0K | $12.20 | $366K |
| May 2, 22 | Jonathan ViolinChief Executive Officer | SELL | 30.0K | $13.04 | $391K |
| Apr 4, 22 | Jonathan ViolinChief Executive Officer | SELL | 3.6K | $18.93 | $68K |
| Apr 1, 22 | Jonathan ViolinChief Executive Officer | SELL | 26.4K | $18.92 | $499K |
| Mar 2, 22 | Jonathan ViolinChief Executive Officer | SELL | 11.1K | $17.36 | $193K |
| Mar 1, 22 | Jonathan ViolinChief Executive Officer | SELL | 18.9K | $17.82 | $337K |
| Feb 3, 22 | Jonathan ViolinChief Executive Officer | SELL | 909 | $19.16 | $17K |
| Feb 2, 22 | Jonathan ViolinChief Executive Officer | SELL | 12.3K | $18.47 | $228K |
| Feb 1, 22 | Jonathan ViolinChief Executive Officer | SELL | 16.8K | $19.55 | $327K |
| Sep 23, 21 | Frazier Life Sciences Public Fund, L.p.TenPercentOwner | BUY | 200.0K | $11.00 | $2.2M |
| Sep 21, 21 | Fairmount Healthcare Fund L.p.DirectorOther | BUY | 909.0K | $11.00 | $10.0M |
Over the past 12 months, insiders at Viridian Therapeutics, Inc.\DE filed 2 open-market purchases worth $30.0M and 1 sale worth $71K on VRDN, which makes them net buyers over the period. The most recent Form 4 was filed on May 11, 26.
The largest recent open-market VRDN insider purchase in our data was $30.0M by Fairmount Healthcare Fund II L.p., Director,TenPercentOwner, filed on Sep 13, 24.
3 different insiders at Viridian Therapeutics, Inc.\DE filed open-market SEC Form 4 transactions on VRDN over the last 12 months.
InsiderTape plots every VRDN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Viridian Therapeutics, Inc.\DE insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →